Long-term efficacy of insulin pump therapy on glycemic control in adults with type 1 diabetes mellitus

  • Orr C
  • Hopman W
  • Yen J
 et al. 
  • 2


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


OBJECTIVE: Continuous subcutaneous insulin infusion (CSII) is an effective method of intensive therapy for patients with type 1 diabetes; however, most studies have not examined long-term glycemic control. We evaluated the long-term efficacy of CSII in a cohort of adult patients with type 1 diabetes. SUBJECTS AND METHODS: This was a retrospective observational study of 200 patients with type 1 diabetes who initiated CSII at a single outpatient clinic in Kingston, ON, Canada between January 1998 and December 2012. Data were collected from 3 months prior to and up to 15 years after initiation of CSII and included glycated hemoglobin (HbA1c) level and demographic factors potentially associated with glycemic control. RESULTS: Mean age and duration of diabetes at CSII initiation were 35.4 years and 22.4 years, respectively. Mean duration of CSII at the time of analysis was 6 years. Mean HbA1c at initiation of CSII was 8.7% and decreased to a nadir of 7.5% 6 months post-initiation (SD = 1.0) (P < 0.001). This increased over time (range, 7.8-8.2%) but remained lower than the pre-CSII HbA1c (P < 0.001). Shorter duration of diabetes prior to CSII initiation, history of missed appointments, mental illness, and active smoking were predictors of higher HbA1c on CSII. Pre-CSII HbA1c predicted long-term HbA1c on CSII. CONCLUSIONS: The data demonstrate that in a clinic setting, patients on CSII maintain lower HbA1c values over a 1-10-year period compared with pre-CSII values. Poor pre-CSII HbA1c, history of missed appointments, mental illness, and active smoking are predictors of those less likely to achieve an HbA1c target of

Author-supplied keywords

  • *Insulin Infusion Systems
  • Adolescent
  • Adult
  • Aged
  • Blood Glucose/analysis/*drug effects
  • Child
  • Diabetes Mellitus, Type 1/blood/*drug therapy
  • Female
  • Hemoglobin A, Glycosylated/analysis/drug effects
  • Humans
  • Hypoglycemic Agents/*administration & dosage
  • Insulin/*administration & dosage
  • Male
  • Middle Aged
  • Ontario
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome
  • Young Adult

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • C J Orr

  • W Hopman

  • J L Yen

  • R L Houlden

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free